Hypoperfusion in the acute phase of subarachnoid hemorrhage

Acta Neurochirurgica, Supplementum

Volumn 110, Issue , 2011, Pages 35-38

  Schubert, Gerrit Alexander ^a   Seiz, Marcel ^a   Hegewald, Aldemar Andrés ^a   Manville, Jérôme ^a   Thomé, Claudius ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Acute phase; Hypoperfusion; Subarachnoid hemorrhage; Vasospasm

Indexed keywords

ASPARTIC ACID; CLAZOSENTAN; ENDOTHELIN RECEPTOR ANTAGONIST; GLUCOSE; GLUTAMIC ACID; LACTIC ACID;

AUTOREGULATION; BRAIN BLOOD FLOW; BRAIN INJURY; BRAIN PERFUSION; BRAIN VASOSPASM; CONFERENCE PAPER; DIFFUSION WEIGHTED IMAGING; INDUCED HYPOTHERMIA; INTRACRANIAL PRESSURE; LASER DOPPLER FLOWMETRY; METABOLIC DISORDER; MICRODIALYSIS; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PROPHYLAXIS; SUBARACHNOID HEMORRHAGE;

EID: 85052610058     PISSN: 00651419     EISSN: 00016268     Source Type: Book Series    
DOI: 10.1007/978-3-7091-0353-1_6     Document Type: Conference Paper

References (10)

1. Jakobsen M, Enevoldsen E, Bjerre P. Cerebral blood flow and metabolism following subarachnoid haemorrhage: Cerebral oxygen uptake and global blood flow during the acute period in patients with SAH. Acta Neurol Scand. 1990;82:174-82.
2. Schubert GA, Poli S, Mendelowitsch A, Schilling L, Thome C. Hypothermia reduces early hypoperfusion and metabolic alterations during the acute phase of massive subarachnoid hemorrhage: A laser-Doppler-flowmetry and microdialysis study in rats. J Neurotrauma. 2008;25:539-48.
3. Schubert GA, Poli S, Schilling L, Heiland S, Thome C. Hypothermia reduces cytotoxic edema and metabolic alterations during the acute phase of massive SAH: A diffusion-weighted imaging and spectroscopy study in rats. J Neurotrauma. 2008;25:841-52.
4. Schubert GA, Schilling L, Thome C. Clazosentan, an endothelin receptor antagonist, prevents early hypoperfusion during the acute phase of massive experimental subarachnoid hemorrhage: A laser Doppler flowmetry study in rats. J Neurosurg. 2008;109: 1134-40.
5. Roos YB, de Haan RJ, Beenen LF, Groen RJ, Albrecht KW, Vermeulen M. Complications and outcome in patients with aneurysmal subarachnoid haemorrhage: A prospective hospital based cohort study in the Netherlands. J Neurol Neurosurg Psychiatry. 2000;68:337-41.
6. Rosenstein J, Suzuki M, Symon L, Redmond S. Clinical use of a portable bedside cerebral blood flow machine in the management of aneurysmal subarachnoid hemorrhage. Neurosurgery 1984;15: 519-25.
7. Bederson JB, Germano IM, Guarino L. Cortical blood flow and cerebral perfusion pressure in a new noncraniotomy model of subarachnoid hemorrhage in the rat. Stroke 1995;26:1086-91; discussion 1091-1082.
8. Thomé C, Schubert GA, Piepgras A, Elste V, Schilling L, Schmiedek P. Hypothermia reduces acute vasospasm following SAH in rats. Acta Neurochir Suppl. 2001;77:255-8.
9. Vajkoczy P, Meyer B, Weidauer S, Raabe A, Thomé C, Ringel Fet al,. Clazosentan (ASV-034343), a selective endothelin A receptor antagonist, in the prevention of cerebral vasospasm follwoing severe aneurysmal subarachnoid hemorrrhage: Results of a randomized, double-blind, placebo-controlled, multicenter Phase IIa study. J Neurosurg. 2005;103:9-17.
10. Proust F, Hannequin D, Langlois O, Freger P, Creissard P. Causes of morbidity and mortality after ruptured aneurysm surgery in a series of 230 patients. The importance of control angiography. Stroke 1995;26:1553-7.